Medicines Access Body Throws More Light On Global mRNA Vaccine Patent Filings
Executive Summary
A new mapping exercise is intended to identify patents filed in relation to the mRNA technology transfer program set up to help lower-income countries build their own mRNA manufacturing facilities.
You may also be interested in...
New COVID-19 Vaccine Patent Database Launched
As part of its drive to maximize global access to coronavirus vaccines, the Medicines Patent Pool has developed a publicly accessible resource giving information on the patent status of approved and candidate vaccines.
EU’s Unitary SPC System Must Maximize Access To Medicines & Not Block Generic Entry
A European Parliament committee says that some aspects of the EU’s proposed unitary supplementary protection certificate scheme could promote access to cheaper off-patent medicines while others could delay generic competition.
Austria & Germany Call For ‘Competitiveness Check’ On EU Pharma Revision Package
The two countries want the European Commission’s proposals to be more closely examined for their possible negative effect on pharmaceutical investment decisions. The industry federation EFPIA says it is surprised more EU member states aren’t taking the same stance.